Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I think RG anticipates a higher share price.

Very simply the more shares on the open market not owned by insiders is an increase to the float...use T shares, even assuming they'd have some time restriction for trading by the issued to entity, would still increase the float. I believe that T shares are not in the equity per share calculations too thus decreasing equity per share.

Share
New Message
Please login to post a reply